How real-world studies complement randomized controlled trials
Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials (15:10).
External Content
Click Play to display this content and agree to third party cookies. (>)
Jean-Pierre Riveline is Professor of Endocrinology and Diabetology at Lariboisière Hospital in Paris, France. He is responsible for the University Center for Diabetes and its Complications (CUDC).
Disclosures
Advisory panel member for: Sanofi, MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab, Insulet and Medtronic.
Research funding and research support: Abbott, Insulet, Medtronic, Air Liquide, Sanofi, Roche and Novo Nordisk.